$192.89 -8.74 (%) Perrigo Company PLC - NYSE

Apr. 24, 2015 | 04:00 PM

Partner Headlines

  1. Mylan 'Raises' Perrigo Bid, But Teva Buzz Builds

    IBD | Apr. 24, 2015 | 17:51PM EST
  2. Worst Performing Industries For April 24, 2015

    Benzinga | Apr. 24, 2015 | 11:16AM EST
  3. Benzinga's M&A Chatter for Wednesday April 22, 2015

    Benzinga | Apr. 22, 2015 | 17:47PM EST
  4. CalAmp and Illumina Significant Earnings Growth; Perrigo Rebuffs Takeover Offer

    GuruFocus | Apr. 22, 2015 | 11:28AM EST
  5. Teva Offers $40 Bil For Mylan; Perrigo Rejects Mylan

    IBD | Apr. 21, 2015 | 19:04PM EST
  6. Teva Offers, Perrigo Rejects

    IBD | Apr. 21, 2015 | 18:51PM EST
  7. Buyers Prop Up Nasdaq; Chipotle Rises Ahead Of Earnings

    IBD | Apr. 21, 2015 | 14:49PM EST
  8. Teva Bids $40 Billion For Mylan, But May Need More

    IBD | Apr. 21, 2015 | 11:35AM EST
  9. Mylan Shares Jump On $40 Billion Bid From Teva Pharmaceutical

    Benzinga | Apr. 21, 2015 | 10:52AM EST
  10. Stocks Slip Into Mixed Trade; DuPont, Harley-Davidson Dive

    IBD | Apr. 21, 2015 | 10:35AM EST
  11. Teva Offers $82 A Share For Mylan; Stocks Rise

    IBD | Apr. 21, 2015 | 09:17AM EST
  12. Stock Futures Mildly Positive; Mylan, Fortinet, Mellanox Surge

    IBD | Apr. 21, 2015 | 09:01AM EST
  13. Benzinga's Weekend M&A Chatter

    Benzinga | Apr. 19, 2015 | 19:10PM EST
  14. Teva Getting Serious About Mylan Bid, Says Report

    IBD | Apr. 17, 2015 | 15:54PM EST
  15. Mylan: There's No Logic In The Teva Merger Rumor

    Benzinga | Apr. 17, 2015 | 15:17PM EST
  16. Mylan Scores Final Win In Patent Challenge On Inhalation Drug

    Benzinga | Apr. 17, 2015 | 14:27PM EST
  17. Top Performing Industries For April 13, 2015

    Benzinga | Apr. 13, 2015 | 10:34AM EST
  18. Worst Performing Industries For March 3, 2015

    Benzinga | Mar. 3, 2015 | 11:17AM EST
  19. Three Reasons To Let Akorn Fall Into Your Portfolio

    IBD | Feb. 6, 2015 | 11:11AM EST
  20. Generic-Drug Makers Soar, And It's Easy To See Why

    IBD | Feb. 5, 2015 | 17:33PM EST
  21. Stocks Rise In Weak Trade; LinkedIn Jumps After Hours

    IBD | Feb. 5, 2015 | 17:03PM EST
  22. Stocks Close Near Session Highs, But Volume Softens

    IBD | Feb. 5, 2015 | 16:18PM EST
  23. Worst Performing Industries For January 22, 2015

    Benzinga | Jan. 22, 2015 | 11:22AM EST
  24. #PreMarket Primer: Wednesday, December 31: Officials Closer To An Answer On AirAsia Jet Crash

    Benzinga | Dec. 31, 2014 | 08:22AM EST
  25. Worst Performing Industries For December 23, 2014

    Benzinga | Dec. 23, 2014 | 11:25AM EST
  26. Stocks Off Highs But Stay Positive; Nike Drags Dow

    IBD | Dec. 19, 2014 | 13:27PM EST
  27. Fournier Finds Time for His Own Investments in the Third Quarter

    GuruFocus | Dec. 17, 2014 | 17:44PM EST
  28. Top Performing Industries For November 24, 2014

    Benzinga | Nov. 24, 2014 | 10:35AM EST
  29. Perrigo to buy Omega Pharma

    IBD | Nov. 6, 2014 | 18:49PM EST
  30. Perrigo Acquires Omega Pharma For $4.5 Billion Euro

    Benzinga | Nov. 6, 2014 | 11:28AM EST
  31. Earnings Scheduled For November 6, 2014

    Benzinga | Nov. 6, 2014 | 05:42AM EST
  32. Benzinga's M&A Chatter for Thursday October 30, 2014

    Benzinga | Oct. 30, 2014 | 21:24PM EST
  33. Perrigo Surges Amid Report Of Omega Pharma Acquisition

    Benzinga | Oct. 30, 2014 | 11:17AM EST
  34. Top Performing Industries For October 30, 2014

    Benzinga | Oct. 30, 2014 | 11:10AM EST
  35. Lannett Co. Gets Growth Rx In Generic Drugs Group

    IBD | Oct. 27, 2014 | 17:59PM EST
  36. Benzinga's M&A Chatter for Monday October 20, 2014

    Benzinga | Oct. 20, 2014 | 19:27PM EST
  37. Perrigo CEO Constructs "Five Pillars" For Success

    IBD | Oct. 17, 2014 | 17:03PM EST
  38. Drugmaker M&A Goes On, With Or Without Tax Inversions

    IBD | Oct. 10, 2014 | 17:37PM EST
  39. Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene

    IBD | Oct. 7, 2014 | 18:33PM EST
  40. Generics Firms Step Up Their Game In Branded Drugs

    IBD | Oct. 6, 2014 | 18:08PM EST
  41. Akorn Upgraded On Strong Generic Drug Trends

    IBD | Sep. 29, 2014 | 12:09PM EST
  42. Multiple Sclerosis Drugs Could Transform Market Again

    IBD | Sep. 26, 2014 | 18:07PM EST
  43. Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers

    IBD | Sep. 13, 2014 | 08:02AM EST
  44. #PreMarket Primer: Wednesday, September 10: Dollar General Gets Aggressive

    Benzinga | Sep. 10, 2014 | 07:38AM EST
  45. Benzinga's Top #PreMarket Losers

    Benzinga | Aug. 18, 2014 | 08:20AM EST
  46. Perrigo gets one-time benefit

    IBD | Aug. 14, 2014 | 18:47PM EST
  47. Perrigo Regains Some Lost Ground On Fiscal Q4 Beat

    IBD | Aug. 14, 2014 | 18:36PM EST
  48. Markets Gather Some Momentum As Volume Remains Light, Geopolitical Tension Improving

    Benzinga | Aug. 14, 2014 | 16:37PM EST
  49. Stocks End With Small Gains; Amgen Shrugs Off Drug Data

    IBD | Aug. 14, 2014 | 16:25PM EST
  50. Perrigo Q4 Beats Estimates, But Guidance Misses

    IBD | Aug. 14, 2014 | 11:02AM EST
Trading Center